Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen Shares Plummet 12 Percent on Weak Q3 Results

NEW YORK (GenomeWeb News) — Shares in Invitrogen were down 11.81 percent, or $7.80, at $58.24 in mid-afternoon trading after the company posted lackluster earnings today.
 
As GenomeWeb News reported, Invitrogen today said third-quarter revenues increased 7 percent while last year’s profit turned to a loss.
 
In a statement, CEO Greg Lucier said that "after three consecutive years of double-digit revenue and earnings growth, we had expectations to achieve similar results this year. That has clearly not happened.
 
"As a result, we are executing plans to refocus the business on those areas where either science or our leading brand can provide meaningful differentiation," said Lucier. "These actions include focusing on improving our go-to-market strategy in regional markets to ensure our sales growth matches the leading reputation we hold for being the quality and technology leader in scientific tools, completing the acquisition integrations, and responsibly reducing our cost structure.”
 
Lucier said these plans “will set the company up for a solid year of execution in 2007.”
 
Not every investor agreed. Citigroup downgraded Invitrogen’s stock to ‘Hold’ from ‘Buy’ today. According to Marketwatch, the bank’s broker said that although the company is close to wrapping up its business review, “management didn't provide sufficient clarity on the potential steps it may take to improve next year's outlook given recent operating margin pressures.”

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.